Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2024-12-04 Remuneration Information
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Share Option Award & PDMR Dealings
Remuneration Information Classification · 1% confidence The document is an official announcement from IXICO plc, identified by the 'RNS Number' header and the reference to RNS as the news service of the London Stock Exchange. The content explicitly details 'Share Option Award & Director Bed & ISA Dealings' involving PDMRs (Persons Discharging Managerial Responsibilities), specifically Robin Wolz and Grant Nash. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of 'Director's Dealing' (DIRS). Although it mentions share option awards, the primary focus and structure follow the regulatory disclosure requirements for insider transactions.
2024-12-04 English
Financial Results for year ended 30 September 2024
Earnings Release Classification · 1% confidence The document explicitly states it announces the 'Financial Results for year ended 30 September 2024 & Notice of AGM'. It contains detailed audited financial figures (£5.8 million Revenues, EBITDA loss of £1.7 million, etc.) typical of a full annual report, and also includes a 'Notice of AGM' section. The text mentions that the 'full Annual Report and Accounts, along with Notice of AGM, will be sent to shareholders on 20 December 2024'. Since this announcement contains the full financial results summary and the AGM notice, and is being released ahead of the formal distribution of the full report, it functions primarily as an Earnings Release (ER) announcing the results, but because it is a comprehensive year-end announcement that includes the formal results and the AGM notice, it is often classified as the primary annual filing document. However, the key differentiator here is the explicit mention that the 'full Annual Report and Accounts' will be sent later. This structure—announcing the results and the AGM date while stating the full report is forthcoming—strongly suggests this is the initial announcement of the annual results, which aligns best with the Earnings Release (ER) category for the financial highlights, or potentially a combined filing. Given the depth of financial detail provided (revenues, margins, EBITDA, cash, NAV) and the inclusion of the Chair's and CEO's statements which review the entire year, it is more substantial than a typical ER. Since it covers the full year's audited results and is released via RNS, it is a strong candidate for a comprehensive annual filing. If the full 10-K document is not present, this RNS announcement containing the audited results for the year ended 30 September 2024 is the closest representation of the Annual Report content released to the market first. However, the presence of the 'Notice of AGM' and the statement that the 'full Annual Report and Accounts' will follow later suggests this specific RNS filing is the official announcement of the results and the AGM, making it an Earnings Release (ER) or a Report Publication Announcement (RPA) if it were shorter. Given the length and content detailing the full year's audited performance, it is best classified as the initial release of the Annual Results, which maps to ER, or potentially a combined filing if '10-K' is interpreted as the content rather than the specific SEC form. Since it contains the full year's audited results, it is more than just a summary. Given the options, and the fact that it contains the full year's audited results, it is closest to the content of a 10-K, but since it is an RNS announcement *about* the results and the AGM, and explicitly states the full report follows, ER is the most accurate classification for this specific announcement document type. FY 2024
2024-12-04 English
Notice of Results and Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is a formal announcement via RNS (London Stock Exchange news service) stating that IXICO plc will issue its 'Full Year Results' on a future date (December 4, 2024). Crucially, it also announces that the CEO and CFO will provide a 'live presentation' regarding these results and strategy on the same day and the following day via two different platforms (Vox and Investor Meet Company). Since the document itself is not the Full Year Results (which would likely be a 10-K or IR), nor is it a transcript of the presentation, but rather an announcement about the upcoming release of results and the associated investor presentation/meeting, it fits best under 'Report Publication Announcement' (RPA) or potentially 'Regulatory Filings' (RNS). Given the specific mention of announcing the publication of results and the associated investor presentation/call, RPA is the most precise fit, as it signals the upcoming release of the main report and related investor engagement.
2024-11-25 English
Share Option Awards & PDMR Dealing
Remuneration Information Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 3194K, dated 31 October 2024). The content explicitly details the 'Grant of Share Options' to Persons Discharging Managerial Responsibilities (PDMRs) like the CEO and CFO, including specific volumes and exercise prices. This type of filing, which reports personal share transactions or option awards by directors/executives, falls under the category of Director's Dealing (DIRS). Although it involves options, the primary function is reporting insider transactions/awards, not a general capital change (SHA) or remuneration report (DEF 14A). Since it is a specific regulatory disclosure about insider transactions, DIRS is the most appropriate code.
2024-10-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is disseminated via 'RNS Number : 2921K' and mentions the 'FCA' (Financial Conduct Authority). This form is used to report changes in significant share ownership thresholds. The filing explicitly details the percentage of voting rights held (8.0621%) and the date the threshold was crossed (28 OCTOBER 2024). This directly corresponds to the definition of a Major Shareholding Notification.
2024-10-30 English
Holding(s) in Company
Director's Dealing Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and is disseminated via 'RNS Number : 1031K'. This form details changes in voting rights held by a shareholder (Octopus Investments Limited) crossing a notification threshold (18.18%). This type of mandatory disclosure regarding insider or major shareholder transactions/holdings aligns directly with the definition of Director's Dealing (DIRS) or, more broadly, a regulatory filing concerning share ownership changes. Since there is no specific code for 'Major Shareholding Notification' other than MRQ (which is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'), and this document is a standard regulatory notification form (TR-1) about crossing a threshold, MRQ is the most appropriate fit. However, looking closely at the provided definitions, MRQ is 'Major Shareholding Notification'. The content is a TR-1 form detailing a change in major holding (18.18%). This is a specific regulatory filing about share ownership change, making MRQ the best fit over the general RNS.
2024-10-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.